StockWatch
·
Pharmaceuticals
Regulatory10 Aug 2026, 05:52 pm

Transchem Ltd: No Deviation in Preferential Issue Proceeds Utilization

AI Summary

Transchem Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026. Issued by Acuite Ratings & Research Limited, the report confirms no deviation in the utilization of proceeds raised through a Preferential Issue of Warrants. The report was reviewed by the Audit Committee and taken on record by the Board of Directors on August 10, 2026. The company raised ₹461.25 Cr through this issue, with an offer price of ₹75.00 per warrant. All utilization is reported to be in line with the disclosures in the Offer Document.

Key Highlights

  • No deviation observed in utilization of preferential issue proceeds.
  • Report covers utilization for the quarter ended June 30, 2026.
  • Acuite Ratings & Research issued the monitoring report.
  • ₹461.25 Cr raised via Preferential Issue of Warrants.
  • Report reviewed by Audit Committee and Board.